生物活性 | |||
---|---|---|---|
描述 | DOCK2-IN-1, analogous to CPYPP, functions as an inhibitor targeting the DOCK2 enzyme, with an IC50 of 19.1 μM. It engages the DOCK2 DHR-2 domain reversibly, impeding its catalytic function. This inhibitor effectively halts the activation of Rac, a GTPase, by both chemokine and antigen receptors in lymphocytes, thereby substantially diminishing chemotactic responses and T cell activation[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.35mL 0.67mL 0.33mL |
16.74mL 3.35mL 1.67mL |
33.48mL 6.70mL 3.35mL |
参考文献 |
---|